Active Shortage

NAT-ERLOTINIB

NATCO PHARMA (CANADA) INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NAT-ERLOTINIB in Canada?

Yes. NAT-ERLOTINIB 25MG has an active shortage reported to Health Canada (last updated April 13, 2026).

When will NAT-ERLOTINIB be available again?

The manufacturer's estimated resolution date is June 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~9 months remaining (estimate)

Affected strength25MG

Last updated2026-04-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

APO-ERLOTINIB

APOTEX INC

25MG · DIN 02461862

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-ERLOTINIB

TEVA CANADA LIMITED

25MG · DIN 02377691

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-06-30

~9 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02483912

Strength

25MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ERLOTINIB

Tier

Unrated

Last Updated

2026-04-13

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from NATCO PHARMA (CANADA) INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

250MG · DIN 02494132

1MG · DIN 02417855

2.5MG · DIN 02492814

5MG · DIN 02492822

100MG · DIN 02496895

25MG · DIN 02496887